Advancing Every Day
Since 1998, Aldevron has been committed to advancing discoveries in biotechnology.

Learn More

mRNA Custom Manufacturing
Complete with LNP Encapsulation and Fill/Finish Capabilities

Learn More

CRISPR RNP-Based Genome Editing in Cell & Gene Therapy

Learn More

Whitepaper:

Expectations on the Pathway to GMP for Gene-Modified Cell Therapies

Download Now

NanoplasmidTM Whitepaper:
Eliminating antibiotic resistance gene transfer risks in cell & gene therapies

Download Now

Aldevron Breakthrough Blog

Read the Latest

Work at Aldevron

Learn More

Platforms

ald-HomepageIcons-plasmid-2019-01

Plasmid DNA Production

High-quality plasmid DNA production for a wide range of research, preclinical, clinical, and diagnostic applications.

Learn more

ald-HomepageIcons-mrna-2019-04

mRNA Production

High-quality, scalable mRNA production meeting a wide range of requirements.

Learn more

ald-HomepageIcons-protein-2019-02

Protein Production

Gene-to-protein services, including custom enzyme production, recombinant antibodies and proteins.

Learn more

Services

research-grade-icon

Research Grade

Our research-grade production facilities provide the flexibility needed to offer competitive pricing and rapid turnaround times while still maintaining the quality our clients expect.

Learn more

gmp-source-icon

GMP-Source®

A faster, cost-effective alternative to cGMP production, GMP-Source® (GMP-S) can be manufactured to standard or customizable specifications.

Learn more

cGMP-Service-Icon

cGMP

Driven by a comprehensive quality assurance process, we produce cGMP plasmid DNA in segregated ISO-classified manufacturing suites ensuring the highest quality products with each and every order.

Learn more

Recent News

Integrated DNA Technologies and Aldevron® Activate Strategic Partnership to Deliver Key CRISPR Components to Cell and Gene Therapy Developers

Under the new agreement, Integrated DNA Technologies (IDT) will sell Aldevron cGMP-manufactured CRISPR nucleases to enable customers to rapidly...

Jennifer Meade Named President

FARGO, N.D. (September 11, 2023) – Jennifer Meade has been named President of Aldevron, effective September 11th 2023, as part of a planned...

Aldevron Signs Licensing Agreement With Genentech

Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA, and proteins for the biotech industry, signed a licensing...

Recent Blog Posts

Collaboration Helps Drive Advancement

Making use of ultra-low endotoxin Cas9 from Aldevron The latest research article from the Innovative Genomics Institute (IGI) at the University of...

LNPs, analytics and mRNA

Working toward advanced analytical techniques Guten tag from Berlin! As an analytically minded-person, it’s fascinating to connect with colleagues...

An ITR Faceoff

AAV ITRs versus Transposon ITRs Inverted Terminal Repeats (ITRs) are DNA sequences flanking the transgene of interest to signal incorporation into...

About Aldevron

We provide high-quality plasmid DNA, proteins, enzymes, and other biologicals to help our partners achieve ground-breaking science throughout a variety of life science applications. From contract services to comprehensive solutions, we supply what you need, when you need it, with expert support at every stage of development and production.

Learn More

Innovative Science. Consistent Biologics. Experienced Partner.

Contact us about our comprehensive development and manufacturing services and how we can help you navigate the entire pharmaceutical development cycle.

 

contact us